<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>From a total of 18,416 bone-marrow biopsy reports entered into the Düsseldorf Bone Marrow Registry between 1975 and 1990 those of patients diagnosed as having <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">preleukaemia</z:e>, myeloid <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:e sem="disease" ids="C0242034" disease_type="Disease or Syndrome" abbrv="">panmyelopathy</z:e> with hypercellular bone marrow, refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo>, sideroblastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> or smoldering <z:mpath ids='MPATH_336'>leukaemia</z:mpath> were reanalyzed together with patient-data </plain></SENT>
<SENT sid="1" pm="."><plain>If the diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) was confirmed, the original blood and bone-marrow smear was re-examined and classified, 584 cases in <z:hpo ids='HP_0000001'>all</z:hpo> (3.2%) </plain></SENT>
<SENT sid="2" pm="."><plain>During the same period <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> had been diagnosed in 506 patients (2.8%) </plain></SENT>
<SENT sid="3" pm="."><plain>The average annual incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in the Düsseldorf area was 3.65 per 100,000 inhabitants </plain></SENT>
<SENT sid="4" pm="."><plain>Over 80% of cases occurred from the age of 60 years, while 7% were younger than 50 years </plain></SENT>
<SENT sid="5" pm="."><plain>The sex ratio was the same in <z:hpo ids='HP_0000001'>all</z:hpo> subgroups of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, except <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (male:female ratio 1:1.57) </plain></SENT>
<SENT sid="6" pm="."><plain>31 patients (5.3%) had received ionizing radiation and/or <z:chebi fb="0" ids="35610">cytostatic</z:chebi> or immunosuppressive treatment for various underlying diseases before <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> had been diagnosed (<z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>Preceding occupational contact with organic solvents could not be excluded with certainty in 12 patients </plain></SENT>
<SENT sid="8" pm="."><plain>These data suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is a relatively frequent disease of hematopoiesis among the older age groups </plain></SENT>
<SENT sid="9" pm="."><plain>The proportion of secondary (treatment-induced) forms is small and does not explain the recently observed increased incidence </plain></SENT>
</text></document>